2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Gelissen J, Adjei N, McNamara B, Mutlu L, Harold J, Clark M, Altwerger G, Dottino P, Huang G, Santin A, Azodi M, Ratner E, Schwartz P, Andikyan V. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Annals Of Surgical Oncology 2023, 30: 5597-5609. PMID: 37358686, DOI: 10.1245/s10434-023-13757-0.Peer-Reviewed Original ResearchConceptsHyperthermic intraperitoneal chemotherapyIntraperitoneal chemotherapyOvarian cancerStage III epithelial ovarian cancerUse of HIPECEpithelial ovarian cancerHigh-quality evidenceOvarian cancer treatmentHIPEC useInterval cytoreductionCytoreductive surgeryNeoadjuvant chemotherapyPerioperative careHIPEC protocolsHIPEC techniqueTreatment modalitiesPatient outcomesSingle administrationTumor disseminationChemotherapyCancerCancer treatmentOptimal candidatesMain siteLife data
2015
Does use of uterine manipulator alter the rate of lymphovascular space invasion in patients with invasive cervical cancer undergoing radical hysterectomy?
Andikyan V, Carroll R, Fields J, Dottino P, Zakashansky K. Does use of uterine manipulator alter the rate of lymphovascular space invasion in patients with invasive cervical cancer undergoing radical hysterectomy? Gynecologic Oncology 2015, 137: 145. DOI: 10.1016/j.ygyno.2015.01.362.Peer-Reviewed Original ResearchSurgical, pathologic and survival outcomes of patients undergoing open, laparoscopic or robotic radical hysterectomy for invasive cervical cancer
Andikyan V, Carroll R, Fields J, Gretz H, Chuang L, Dottino P, Zakashansky K. Surgical, pathologic and survival outcomes of patients undergoing open, laparoscopic or robotic radical hysterectomy for invasive cervical cancer. Gynecologic Oncology 2015, 137: 144-145. DOI: 10.1016/j.ygyno.2015.01.361.Peer-Reviewed Original ResearchHyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: Single institutional experience
Andikyan V, Tabrizian P, Farag S, Fields J, Kolev V, Rahaman J, Fishman D, Sarpel U, Zakashansky K, Labow D. Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: Single institutional experience. Gynecologic Oncology 2015, 137: 173-174. DOI: 10.1016/j.ygyno.2015.01.434.Peer-Reviewed Original ResearchRole of laparoscopy in determining optimal cytoreduction in patients with ovarian, fallopian tube and primary peritoneal cancer
Andikyan V, Kim A, Sierra T, Gretz H, Zakashansky K, Segna R, Beddoe A, Dottino P, Mandeli J, Chuang L. Role of laparoscopy in determining optimal cytoreduction in patients with ovarian, fallopian tube and primary peritoneal cancer. Gynecologic Oncology 2015, 137: 103. DOI: 10.1016/j.ygyno.2015.01.255.Peer-Reviewed Original Research
2013
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer
Sandadi S, Long K, Andikyan V, Vernon J, Sonoda Y, Barakat R, Chi D. Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer. Gynecologic Oncology 2013, 130: e110. DOI: 10.1016/j.ygyno.2013.04.320.Peer-Reviewed Original ResearchCervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: Is less enough?
Andikyan V, Khoury-Collado F, Denesopolis J, Sandadi S, Park K, Brown C, Sonoda Y, Chi D, Barakat R, Abu-Rustum N. Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: Is less enough? Gynecologic Oncology 2013, 130: e50. DOI: 10.1016/j.ygyno.2013.04.179.Peer-Reviewed Original Research